# High- and Low-dose Radiotherapy Combined With PD-1 Inhibitors for MSS CRLM

> **NCT06045286** · PHASE1 · UNKNOWN · sponsor: **Jiangsu Cancer Institute & Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Colorectal Liver Metastases

## Interventions

- **RADIATION:** Radiation: High- and Low-dose radiotherapy
- **DRUG:** PD-1 Inhibitors

## Key facts

- **NCT ID:** NCT06045286
- **Lead sponsor:** Jiangsu Cancer Institute & Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-09-20
- **Primary completion:** 2024-09-30
- **Final completion:** 2025-12-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2023-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06045286

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06045286, "High- and Low-dose Radiotherapy Combined With PD-1 Inhibitors for MSS CRLM". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06045286. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*